United Therapeutics Corporation (UTHR) — Long-term Investment Intensity
United Therapeutics Corporation (UTHR) has a Long-term Investment Intensity of 21.3% as of September 2025. Long-term investments of $1.57 Billion represent 21.3% of total assets of $7.35 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See UTHR net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
United Therapeutics Corporation Long-term Investment Intensity (2010–2024)
This chart shows how United Therapeutics Corporation's Long-term Investment Intensity has evolved across 14 annual periods from 2010 to 2024. As of September 2025, the intensity stands at 21.3%, reflecting long-term investments of $1.57 Billion against total assets of $7.35 Billion USD. Also explore United Therapeutics Corporation (UTHR) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for United Therapeutics Corporation (2010–2024)
The table below presents the year-by-year Long-term Investment Intensity for United Therapeutics Corporation from 2010 to 2024, covering 14 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of United Therapeutics Corporation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 20.0% | $1.48 Billion | $7.36 Billion | ▼ -6.6 pp |
| 2023 | 26.6% | $1.91 Billion | $7.17 Billion | ▲ +4.9 pp |
| 2022 | 21.8% | $1.32 Billion | $6.04 Billion | ▼ -10.1 pp |
| 2021 | 31.9% | $1.65 Billion | $5.17 Billion | ▲ +7.0 pp |
| 2020 | 24.9% | $1.15 Billion | $4.62 Billion | ▲ +5.3 pp |
| 2019 | 19.6% | $767.50 Million | $3.91 Billion | ▲ +6.6 pp |
| 2018 | 13.0% | $442.60 Million | $3.40 Billion | ▼ -4.4 pp |
| 2017 | 17.5% | $502.70 Million | $2.88 Billion | ▲ +17.4 pp |
| 2016 | 0.1% | $2.30 Million | $2.33 Billion | ▼ -1.6 pp |
| 2015 | 1.7% | $38.00 Million | $2.18 Billion | ▼ -4.8 pp |
| 2014 | 6.5% | $122.66 Million | $1.88 Billion | ▼ -15.0 pp |
| 2013 | 21.5% | $448.13 Million | $2.09 Billion | ▼ -1.2 pp |
| 2011 | 22.7% | $343.90 Million | $1.52 Billion | ▲ +13.4 pp |
| 2010 | 9.3% | $132.85 Million | $1.43 Billion | — |